RT Journal Article
SR Electronic
T1 Non-communicable diseases Prevalence by HIV Status in East Africa: A protocol for a systematic review and Meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.05.23299514
DO 10.1101/2023.12.05.23299514
A1 Kasango, Asani
A1 Daama, Alex
A1 Negesa, Lilian
YR 2023
UL http://medrxiv.org/content/early/2023/12/06/2023.12.05.23299514.abstract
AB Introduction Over the past decade, HIV care and treatment programs have grown exponentially, resulting in improved survival among persons living with HIV. In the same period, the prevalence of non-communicable diseases has been reported to be higher among people living with HIV as compared to their HIV-negative counterparts. In this review, we aim to assess the prevalence of non-communicable diseases stratified by HIV status in East Africa.Methods We plan to assess observational studies especially case-control, cohort, and cross-sectional studies and clinical trials. These studies will be related to non-communicable diseases and done in East Africa. This review will be for studies done in East Africa from 1st Jan 2013 to 31st Dec 2023. The team will search databases such as East African Medical Journal, PubMed, Pan African Medical Journal, Scopus, African Health Sciences Journal, African Index, Medicus, and African Journals Online among others. We will use subheadings such as HIV, NCDs, and East Africa to search for relevant Journals. The I2 will be used to assess the heterogeneity of individual studies. All statistical analyses will be performed in STATA V15, and results will be graphically presented on a forest plot.Discussion With the rising burden of non-communicable diseases globally, there is much to learn whether the prevalence differs by HIV status or not.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableN/A